Advancing Care of Primary Aldosteronism in Japan Study

Advancing Care of Primary Aldosteronism in Japan Study - Japan Primary Aldosteronism Study 2

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046631

Enrollment

6000

Registered

2022-04-01

Start date

2022-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary aldosteronsim:PA essential hypertension:EHT

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed as PA or EHT between January 2006 and Mar 2026 in JPAS 2 participating centers

Exclusion criteria

Exclusion criteria: Patients who were judged not eligible for the study by respective attending physician

Design outcomes

Primary

Measure	Time frame
1) baseline information,biochemical data, results of confirmatory tests, imaging findings and post-treatment outcomes 2) protocol,decision criteria of AVS 3) treatments and outcomes 4) cost effectiveness	—

Secondary

Measure	Time frame
1)Pathological findings 2)Markers of target organ damage:Kidney(eGFR,BUN,Cr),Heart(ECG,CTR) 3)Clinical course(6M,1Y,3Y,5Y):base line informations, Laboratory data 4)Immunohistochemical staining	—

Countries

Japan

Contacts

Public ContactKenichi Yokota

St. Marianna University School of Medicine Division of Metabolism and Endocrinology, Department of Internal Medicine

jpas2@marianna-u.ac.jp044-977-8111

Outcome results